“…Active nanotech-based research has yielded several new advancements with wide-ranging applications [ 14 , 15 ]. New therapeutic efforts have been concentrated on the design of nanocarriers like polymeric nanoparticles [ 16 , 17 ], inorganic nanoparticles [ 18 , 19 , 20 , 21 ], green synthesized NPs [ 22 , 23 , 24 ], liposomes [ 25 ], nanofibers [ 26 ], hydrogels [ 27 , 28 , 29 ], Niosomes [ 30 , 31 , 32 ], and microemulsions [ 33 , 34 ] to transport therapeutic and diagnostic agents. In light of this fact, the above-mentioned nanoparticles (NPs) have attracted much attention thanks to their relatively high drug loading ability, lower or no systematic toxicity, controlled drug release, extended blood circulation time, capability of targeted delivery, and physical–chemical stability [ 35 , 36 , 37 , 38 ].…”